Key result
AI-QCT total plaque volume is linked to ~56% higher CV death or MI risk per 559 mm³.
Why the study?
Does the addition of AI-QCT-derived atherosclerotic plaque quantification and characterization to baseline risk factors improve the prediction of cardiovascular death or myocardial infarction in patients from the ISCHEMIA trial?
Observational (n=3,711)
Does the addition of AI-QCT-derived atherosclerotic plaque quantification and characterization to baseline risk factors improve the prediction of cardiovascular death or myocardial infarction in patients from the ISCHEMIA trial?
Answers are grounded in this paper and cite their sources.
In the high-risk ISCHEMIA trial population, total plaque volume measured by AI-QCT on baseline CCTA was independently associated with cardiovascular death or myocardial infarction and modestly improved risk prediction beyond traditional baseline risk factors.
Background and Aims The aim of this study was to determine the prognostic value of coronary computed tomography angiography (CCTA)–derived atherosclerotic plaque analysis in ISCHEMIA. Methods Atherosclerosis imaging quantitative computed tomography (AI-QCT) was performed on all available baseline CCTAs to quantify plaque volume, composition, and distribution. Multivariable Cox regression was used to examine the association between baseline risk factors (age, sex, smoking, diabetes, hypertension, ejection fraction, prior coronary disease, estimated glomerular filtration rate, and statin use), number of diseased vessels, atherosclerotic plaque characteristics determined by AI-QCT, and a composite primary outcome of cardiovascular death or myocardial infarction over a median follow-up of 3.3 (interquartile range 2.2–4.4) years. The predictive value of plaque quantification over risk factors was compared in an area under the curve (AUC) analysis. Results Analysable CCTA data were available from 3711 participants (mean age 64 years, 21% female, 79% multivessel coronary artery disease). Amongst the AI-QCT variables, total plaque volume was most strongly associated with the primary outcome (adjusted hazard ratio 1.56, 95% confidence interval 1.25–1.97 per interquartile range increase [559 mm3]; P = .001). The addition of AI-QCT plaque quantification and characterization to baseline risk factors improved the model’s predictive value for the primary outcome at 6 months (AUC 0.688 vs. 0.637; P = .006), at 2 years (AUC 0.660 vs. 0.617; P = .003), and at 4 years of follow-up (AUC 0.654 vs. 0.608; P = .002). The findings were similar for the other reported outcomes. Conclusions In ISCHEMIA, total plaque volume was associated with cardiovascular death or myocardial infarction. In this highly diseased, high-risk population, enhanced assessment of atherosclerotic burden using AI-QCT-derived measures of plaque volume and composition modestly improved event prediction.
No takes yet. Share an insight, caveat, or question.
Nurmohamed et al. (2024) conducted an observational in Coronary artery disease (n=3,711). Total plaque volume by AI-QCT on CCTA (per IQR increase [559 mm3]) vs. Baseline clinical risk factors and number of diseased vessels was evaluated on Composite of cardiovascular death or myocardial infarction (HR 1.56, 95% CI 1.25-1.97, p=0.001). Total plaque volume on AI-QCT was associated with cardiovascular death or MI and modestly improved risk prediction.
Synapse has enriched 10 related papers. Consider them for comparative context: